Interest in biotechnology industries led us to buy Amgen, Celera, and Human Genome Sciences for the Rule Breaker portfolio.
Tissue engineering is another biotech industry with truly awesome potential.
A number of companies compete, and some even have real-live products generating actual revenues. It's not science fiction anymore, but the field's top two researchers say it's just starting. The poisons had the skull and crossbones on the bottles. Scared the heck out of me. Those bottles were uncompromisingly honest, and a little fear can help you make better decisions.